European Heart Journal-Quality of Care and Clinical Outcomes

Papers
(The H4-Index of European Heart Journal-Quality of Care and Clinical Outcomes is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology167
Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990–2017: results from the Global Burden of Disease Study 2017147
Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990–2017: results from the Global Burden of Disease Study 2017118
Atrial fibrillation in the UK: predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs105
The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review103
Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic68
Emergency hospital admissions and interventional treatments for heart failure and cardiac arrhythmias in Germany during the Covid-19 outbreak: insights from the German-wide Helios hospital network58
Impact of COVID-19 on cardiac procedure activity in England and associated 30-day mortality50
Substantial decline in hospital admissions for heart failure accompanied by increased community mortality during COVID-19 pandemic49
Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown?46
Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: results from the All Nippon AF In the Elderly (ANAFIE) Registry45
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomes43
Cardiovascular comorbidities as predictors for severe COVID-19 infection or death40
Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation40
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)39
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews34
European Society of Cardiology: cardiovascular disease statistics 2021: Executive Summary31
Types of myocardial injury and mid-term outcomes in patients with COVID-1927
Peak oxygen consumption achieved at the end of cardiac rehabilitation predicts long-term survival in patients with coronary heart disease27
Impact of frailty on outcomes in elderly patients with acute myocardial infarction who undergo percutaneous coronary intervention25
The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis24
Myocarditis and pericarditis in adolescents after first and second doses of mRNA COVID-19 vaccines24
Pneumococcal vaccination in adults at very high risk or with established cardiovascular disease: systematic review and meta-analysis23
Predictors of pacemaker implantation after transcatheter aortic valve implantation according to kind of prosthesis and risk profile: a systematic review and contemporary meta-analysis23
Refined staging classification of cardiac damage associated with aortic stenosis and outcomes after transcatheter aortic valve implantation23
0.034286022186279